olanzapine pamoate monohydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial AUST R: 143636Active ingredients:
olanzapine pamoate monohydrate
Dosage form:
Injection, powder for
Sponsor:
Pharmaco Australia Ltd
Phone:
1800201564
|
From
19 Dec 2025
to
16 Oct 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
An overseas-registered product has been approved for supply under Section 19A. The approval holder, Aborns Pharmaceuticals Pty Ltd, can be contacted for details on supply on 1300 117 772.
|
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300mg powder for injection vial with diluent vial AUST R: 143657Active ingredients:
olanzapine pamoate monohydrate
Dosage form:
Injection, powder for
Sponsor:
Pharmaco Australia Ltd
Phone:
1800201564
|
From
02 Nov 2026
to
27 Nov 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
Sponsor working to expedite next shipment.
|